Trump contradicts CDC director on vaccines: 'he was confused'
U.S. President Donald Trump speaks to reporters during a news conference in the Brady Press Briefing Room at the White House in Washington, U.S., September 16, 2020. REUTERS/Leah Millis
WASHINGTON (Reuters) - U.S. President Donald Trump predicted on Wednesday at least 100 million doses of a coronavirus vaccine could be distributed in by the end of 2020, contradicting a top government health official Trump dismissed as confused.
Hours earlier, Robert Redfield, director of the federal Centers for Disease Control and Prevention, said a COVID-19 vaccine could be broadly rolled out by the middle of next year or a little later.
"No I think he made a mistake when he said that," Trump said, telling reporters he called Redfield. "That's incorrect information. "I believe he was confused. I think he just misunderstood the question, probably."
Redfield, head of the federal government's disease control agency, made his comments in testimony before a U.S. Senate panel
He said general availability of a vaccine could come by "late second quarter, third quarter 2021."
A vaccine could be ready as soon as this November or December, Redfield said, adding that limited first doses could go to those who were most vulnerable. But "in order to have enough of us immunized to have immunity, I think it’s going to take six to nine months," he added.
(Reporting by Alexandra Alper and Steve Holland; Writing by Doina Chiacu; Editing by Sandra Maler and David Gregorio)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kennedy Center on brink of bankruptcy, could close as early as Tuesday, Washington Post reports
- Diplomacy stumbles with postponement of meeting on Strait of Hormuz proposal
- Chinese defence forum set to open amid roiling regional tensions
Create E-mail Alert Related Categories
General News, ReutersRelated Entities
Donald J. TrumpSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share